Terms: = Thyroid cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802
99 results:
1. Absolute lymphocyte count and neutrophil-to-lymphocyte ratio as predictors of CDK 4/6 inhibitor efficacy in advanced breast cancer.
Nakamoto S; Shien T; Iwamoto T; Kubo S; Yamamoto M; Yamashita T; Kuwahara C; Ikeda M
Sci Rep; 2024 Apr; 14(1):9869. PubMed ID: 38684839
[TBL] [Abstract] [Full Text] [Related]
2. Efficacy of cdk4/6 inhibitors combined with endocrine therapy in HR+/HER2- breast cancer: an umbrella review.
Pu D; Xu D; Wu Y; Chen H; Shi G; Feng D; Zhang M; Liu Z; Li J
J Cancer Res Clin Oncol; 2024 Jan; 150(1):16. PubMed ID: 38240835
[TBL] [Abstract] [Full Text] [Related]
3. TIROSEC: Molecular, Clinical and Histopathological Profile of Papillary thyroid Carcinoma in a Colombian Cohort.
Cruz-Romero SD; González S; Juez JY; Becerra DS; Baldión AM; Hakim JA; González-Devia D; Perdomo S; Rodríguez-Urrego PA
Adv Ther; 2024 Feb; 41(2):792-805. PubMed ID: 38170436
[TBL] [Abstract] [Full Text] [Related]
4. cdk4 phosphorylation status and rational use for combining cdk4/6 and BRAF/MEK inhibition in advanced thyroid carcinomas.
Pita JM; Raspé E; Coulonval K; Decaussin-Petrucci M; Tarabichi M; Dom G; Libert F; Craciun L; Andry G; Wicquart L; Leteurtre E; Trésallet C; Marlow LA; Copland JA; Durante C; Maenhaut C; Cavaco BM; Dumont JE; Costante G; Roger PP
Front Endocrinol (Lausanne); 2023; 14():1247542. PubMed ID: 37964967
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA EILA promotes cdk4/6 inhibitor resistance in breast cancer by stabilizing cyclin E1 protein.
Cai Z; Shi Q; Li Y; Jin L; Li S; Wong LL; Wang J; Jiang X; Zhu M; Lin J; Wang Q; Yang W; Liu Y; Zhang J; Gong C; Yao H; Yao Y; Liu Q
Sci Adv; 2023 Oct; 9(40):eadi3821. PubMed ID: 37801505
[TBL] [Abstract] [Full Text] [Related]
6. Comparative efficacy and safety of different combinations of three cdk4/6 inhibitors with endocrine therapies in HR+/HER-2 - metastatic or advanced breast cancer patients: a network meta-analysis.
Liu Y; Wu J; Ji Z; Chen L; Zou J; Zheng J; Lin W; Cai J; Chen Y; Zheng D; Chen Y; Li Z
BMC Cancer; 2023 Aug; 23(1):816. PubMed ID: 37653504
[TBL] [Abstract] [Full Text] [Related]
7. p18INK4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer.
Bai F; Liu X; Zhang X; Mao Z; Wen H; Ma J; Pei XH
Cell Cycle; 2023 Jul; 22(13):1637-1653. PubMed ID: 37345432
[TBL] [Abstract] [Full Text] [Related]
8. Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of cdk4/6 Inhibition.
Hu Q; Huang T
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240281
[TBL] [Abstract] [Full Text] [Related]
9. Differentiated thyroid cancer in Adolescents: Single Center Experience and Considerations for Surgical Management and Radioiodine Treatment.
Chiapponi C; Hartmann MJM; Decarolis B; Simon T; Bruns CJ; Faust M; Schultheis AM; Schmidt M; Alakus H
J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):257-263. PubMed ID: 36987773
[TBL] [Abstract] [Full Text] [Related]
10. The effects of Abemaciclib on cell cycle and apoptosis regulation in anaplastic thyroid cancer cells.
Abutorabi ES; Poursheikhani A; Kashani B; Shamsaiegahkani S; Haghpanah V; Bashash D; Mousavi SA; Momeny M; Ghaffari SH
Mol Biol Rep; 2023 May; 50(5):4073-4082. PubMed ID: 36877344
[TBL] [Abstract] [Full Text] [Related]
11. Assessment of Social Vulnerability in Pediatric Head and Neck cancer Care and Prognosis in the United States.
Fei-Zhang DJ; Chelius DC; Patel UA; Smith SS; Sheyn AM; Rastatter JC
JAMA Netw Open; 2023 Feb; 6(2):e230016. PubMed ID: 36800183
[TBL] [Abstract] [Full Text] [Related]
12. Palbociclib plus endocrine therapy in hormone receptor-positive and HER2 negative metastatic breast cancer: a multicenter real-world study in the northwest of China.
Yang J; Zhao B; Ling X; Li D; Zhao J; Lv Y; Wang G; Liu X; Li N; Yang J
BMC Cancer; 2023 Jan; 23(1):103. PubMed ID: 36717797
[TBL] [Abstract] [Full Text] [Related]
13. Role of synaptotagmin 13 (SYT13) in promoting breast cancer and signaling pathways.
Zhang YD; Zhong R; Liu JQ; Sun ZX; Wang T; Liu JT
Clin Transl Oncol; 2023 Jun; 25(6):1629-1640. PubMed ID: 36630025
[TBL] [Abstract] [Full Text] [Related]
14. Disulfiram/Copper Suppresses cancer Stem Cell Activity in Differentiated thyroid cancer Cells by Inhibiting BMI1 Expression.
Ni YL; Chien PJ; Hsieh HC; Shen HT; Lee HT; Chen SM; Chang WW
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362068
[TBL] [Abstract] [Full Text] [Related]
15. Increased trend of thyroid cancer in childhood over the last 30 years in EU countries: a call for the pediatric surgeon.
Spinelli C; Ghionzoli M; Oreglio C; Sanna B; De Napoli L; Morganti R; Antonelli A; Morabito A; Miccoli P
Eur J Pediatr; 2022 Nov; 181(11):3907-3913. PubMed ID: 36044066
[TBL] [Abstract] [Full Text] [Related]
16. cdk4/6 inhibitor resistance mechanisms and treatment strategies (Review).
Huang J; Zheng L; Sun Z; Li J
Int J Mol Med; 2022 Oct; 50(4):. PubMed ID: 36043521
[TBL] [Abstract] [Full Text] [Related]
17. Overexpressed Cyclin D1 and cdk4 proteins are responsible for the resistance to cdk4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors.
Cai Z; Wang J; Li Y; Shi Q; Jin L; Li S; Zhu M; Wang Q; Wong LL; Yang W; Lai H; Gong C; Yao Y; Liu Y; Zhang J; Yao H; Liu Q
Sci China Life Sci; 2023 Jan; 66(1):94-109. PubMed ID: 35982377
[TBL] [Abstract] [Full Text] [Related]
18.
Zhou X; Lin L; Qi Y; Xu M; Xu Q; Wang Y; Qu J
Dis Markers; 2022; 2022():2562595. PubMed ID: 35968508
[TBL] [Abstract] [Full Text] [Related]
19. Search for New Target Genes of MicroRNA for Differential Diagnosis of Benign and Malignant Neoplasms of the thyroid Gland by In Silico Methods.
Kononchuk VV; Kopeikina EV; Kalinina TS; Saik OV; Alekseenok EY; Kolyagina MK; Matashova VA; Shevchenko SP; Gulyaeva LF; Kushlinskii NE
Bull Exp Biol Med; 2022 Jun; 173(2):246-251. PubMed ID: 35737153
[TBL] [Abstract] [Full Text] [Related]
20. Primary Malignant Peripheral Nerve Sheath Tumor of the Stomach: A Rare Case Report and Review of Literature.
Cui W; Xing L; Fu L; Shi L; Li X
Int J Surg Pathol; 2023 Apr; 31(2):221-226. PubMed ID: 35491655
[TBL] [Abstract] [Full Text] [Related]
[Next]
